Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Applied DNA Sciences Inc APDN

Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.


NDAQ:APDN - Post by User

Post by turner20001on Jan 24, 2024 5:48pm
47 Views
Post# 35843949

500 FACTUAL Reasons to SELL this DUMPSTER Stock!

500 FACTUAL Reasons to SELL this DUMPSTER Stock!500 FACTUAL Reasons to SELL this DUMPSTER Stock!
451. CEO Hayward is now involved with experimental saRNA research and mRNA Therapeutic research.
452. Clinical trials are many years away. This is something Hayward does not disclose.
453. Large companies like Moderna are also doing similar research.
454. Moderna is a multibillion dollar company with hundreds of scientists and with an R & D program funded with billions of dollars.
455. In fact, Moderna spent $3.295 billion on research and development in 2022.
456. I’d like to know how can pip-squeak penny-stock Applied DNA Junk Sciences with just a few million dollars for R & D compete with Moderna? The answer is they CAN’T!
457. It usually takes around 10 years or longer before we will have FDA certified treatments using mRNA Therapeutics and saRNA.
458. In other words, companies hoping to cash in on this technology will have to wait at least 10 years before these products can be commercialized and revenues start coming in.
459. CEO Hayward’s mRNA therapeutics is a hoax!
460. CEO Hayward’s latest business model is a recipe for failure. To keep his company alive, Hayward needs to immediately find a way to grow revenues. Unfortunately, over the past 20 years Hayward has never been able to accomplish this. Future prospects for APDN look disastrous.

<< Previous
Bullboard Posts
Next >>